110 related articles for article (PubMed ID: 30962003)
1. Decreased expression levels of DAL-1 and TOB1 are associated with clinicopathological features and poor prognosis in gastric cancer.
Guo H; Zhang R; Afrifa J; Wang Y; Yu J
Pathol Res Pract; 2019 Jun; 215(6):152403. PubMed ID: 30962003
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.
Li BS; Zuo QF; Zhao YL; Xiao B; Zhuang Y; Mao XH; Wu C; Yang SM; Zeng H; Zou QM; Guo G
Oncogene; 2015 May; 34(20):2556-65. PubMed ID: 25043310
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of cytoplasmic transducer of ErbB2. 1 expression in gastric cancer.
Zhang SQ; Sun KK; Wu XY; Zhong N; Zhao H; Li DC
Mol Med Rep; 2015 Jul; 12(1):1177-82. PubMed ID: 25760308
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
[TBL] [Abstract][Full Text] [Related]
5. Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma.
Jung WY; Kang Y; Lee H; Mok YJ; Kim HK; Kim A; Kim BH
Histopathology; 2013 Oct; 63(4):474-81. PubMed ID: 23889297
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
Tang C; Gao X; Liu H; Jiang T; Zhai X
Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
[TBL] [Abstract][Full Text] [Related]
7. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.
Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M
Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618
[TBL] [Abstract][Full Text] [Related]
8. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
Suh JH; Won KY; Kim GY; Bae GE; Lim SJ; Sung JY; Park YK; Kim YW; Lee J
Int J Clin Exp Pathol; 2015; 8(11):14608-18. PubMed ID: 26823784
[TBL] [Abstract][Full Text] [Related]
9. Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer.
Lin JX; Xie XS; Weng XF; Zheng CH; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Huang CM
World J Gastroenterol; 2018 Sep; 24(34):3898-3907. PubMed ID: 30228783
[TBL] [Abstract][Full Text] [Related]
10. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
Zhao P; Lu Y; Liu L
Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222
[TBL] [Abstract][Full Text] [Related]
11. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
12. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
Hu X; Huang Z; Liao Z; He C; Fang X
Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
[TBL] [Abstract][Full Text] [Related]
13. Cadherin 5 expression correlates with poor survival in human gastric cancer.
Higuchi K; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
J Clin Pathol; 2017 Mar; 70(3):217-221. PubMed ID: 27466381
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma.
Cui M; Yu W; Dong J; Chen J; Zhang X; Liu Y
Med Oncol; 2010 Sep; 27(3):632-9. PubMed ID: 19554484
[TBL] [Abstract][Full Text] [Related]
15. The overexpression of MDM4: an effective and novel predictor of gastric adenocarcinoma lymph node metastasis.
Bao J; Nanding A; Song H; Xu R; Qu G; Xue Y
Oncotarget; 2016 Oct; 7(41):67212-67222. PubMed ID: 27626496
[TBL] [Abstract][Full Text] [Related]
16. Fascin expression is related to poor survival in gastric cancer.
Kim SJ; Kim DC; Kim MC; Jung GJ; Kim KH; Jang JS; Kwon HC; Kim YM; Jeong JS
Pathol Int; 2012 Dec; 62(12):777-84. PubMed ID: 23252866
[TBL] [Abstract][Full Text] [Related]
17. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis.
Bai Z; Ye Y; Chen D; Shen D; Xu F; Cui Z; Wang S
APMIS; 2007 Dec; 115(12):1383-90. PubMed ID: 18184409
[TBL] [Abstract][Full Text] [Related]
18. Low expression of PDHA1 predicts poor prognosis in gastric cancer.
Song L; Liu D; Zhang X; Zhu X; Lu X; Huang J; Yang L; Wu Y
Pathol Res Pract; 2019 Mar; 215(3):478-482. PubMed ID: 30611622
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
